Safety of pandemic (H1N1) 2009 monovalent vaccines in taiwan: a self-controlled case series study.
In Taiwan, new H1N1 monovalent vaccines without adjuvant and with MF59® adjuvant were used in the nationwide vaccination campaign beginning on November 1, 2009. From November 2009 through February 2010, the authors identified recipients of H1N1 vaccines who were diagnosed with adverse events of spec...
Guardado en:
Autores principales: | Wan-Ting Huang, Hsu-Wen Yang, Tzu-Lin Liao, Wan-Jen Wu, Shu-Er Yang, Yi-Chien Chih, Jen-Hsiang Chuang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3b28155b52424408830fc1ea2a626873 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients.
por: João L Miraglia, et al.
Publicado: (2011) -
Monovalent lanthanide(I) in borozene complexes
por: Wan-Lu Li, et al.
Publicado: (2021) -
Amino acids transitioning of 2009 H1N1pdm in Taiwan from 2009 to 2011.
por: Guang-Wu Chen, et al.
Publicado: (2012) -
CLINICAL TRIAL OF THE PANDEMIC INFLUENZA MONOVALENT VACCINE PANDEFLU
por: M. K. Erofeeva, et al.
Publicado: (2014) -
EVALUATION OF IMMUNOLOGICAL SHIFTS IN ADULTS AFTER IMMUNIZATION AGAINST INFLUENZA WITH A SUBUNIT-BASED, ABSORBED MONOVALENT VACCINE STRAIN A/CALIFORNIA/7/2009/(H1N1)
por: M. P. Kostinov, et al.
Publicado: (2014)